Akumentis Healthcare first synthetic CBD for epilepsy January 10, 2024 Akumentis Healthcare Limited, pharma major, has launched Clasepi – DCGI-approved prescription cannabidiol (CBD] specifically formulated to address seizures linked with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or... Trending Air pollution spikes inflammation in patients with heart disease: Study ‘Health Award Scam: Give 75 thousand and take the award of your choice’ Important to ensure medicines, medical products produced in India are of highest quality: Mandaviya Latest Air pollution spikes inflammation in patients with heart disease: Study Health ministry writes to all states on alarming air pollution, fire incidents ‘Antimicrobial Resistance a global health threat’ ICMR starts first in-human clinical trials for Zika vaccine
